Stay updated on Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A sitewide banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T14:49:20.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2. The page otherwise displays a 403 Forbidden error instead of study details.
    Difference
    0.2%
    Check dated 2026-10-18T15:12:11.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:45:00.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, with standard site chrome around it, indicating restricted access rather than the study content.
    Difference
    21%
    Check dated 2026-09-20T19:55:25.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    NIH grant year notes for 2016 and 2023 were added. The page revision label was updated to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.2%
    Check dated 2026-08-30T21:57:47.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Data-sharing and sponsor sections were added, including an IPD Sharing URL and IPD Plan Description. A PDF link for the Study Protocol and SAP was included, and PubMed references with MeSH terms were updated to provide broader context.
    Difference
    67%
    Check dated 2026-08-16T17:06:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.